Brooklyn ImmunoTherapeutics Inc
BTX
4
|
$4.102
-93.91%
|
Information
(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (2.5% 3d) (0.0% 7d) (768.24% volume)
Earnings Calendar: 2022-11-08
Market Cap: $ 241,303,181
https://brooklynitx.com
Sec Filling | Patents | 2018 employees
Brooklyn is focused on exploring the role that cytokine-based therapy can have in treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies. The company is also exploring opportunities to advance therapies using leading edge gene editing/cell therapy technology through its option agreements with Factor Bioscience and Novellus. Brooklyn’s most advanced program is studying the safety and efficacy of IRX-2 in patients with head and neck cancer. In a Phase 2A clinical trial in head and neck cancer, IRX-2 demonstrated an overall survival benefit. Additional studies are either underway or planned in other solid tumor cancer indications.
cancer t-cell msa ceiling
add to watch list Paper trade email alert is off
Press-releases
Brooklyn ImmunoTherapeutics Announces Third Quarter 2021 Financial Results
Published: 2021-11-09 (Crawled : 22:00) - globenewswire.com
BTX 4 | $4.102 -93.91%
|
Information
|
| O: -1.65%
H: 1.56%
C: -9.71%
financial results results
Brooklyn ImmunoTherapeutics to Move Stock Exchange Listing to Nasdaq
Published: 2021-10-14 (Crawled : 21:00) - globenewswire.com
BTX 4 | $4.102 -93.91%
|
Information
|
| O: 3.62%
H: 0.0%
C: -3.17%
nasdaq
Brooklyn ImmunoTherapeutics Reports Inducement Grants
Published: 2021-09-23 (Crawled : 21:00) - globenewswire.com
BTX 4 | $4.102 -93.91%
|
Information
|
| O: -1.59%
H: 2.41%
C: -4.05%
granted report grant
Brooklyn ImmunoTherapeutics Appoints Roger Sidhu, M.D. as Chief Medical Officer
Published: 2021-09-22 (Crawled : 14:15) - globenewswire.com
BTX 4 | $4.102 -93.91%
|
Information
|
| O: 0.62%
H: 1.75%
C: 0.31%
Brooklyn ImmunoTherapeutics Provides Highlights of Shareholder Update Call from September 20, 2021
Published: 2021-09-21 (Crawled : 13:00) - globenewswire.com
BTX 4 | $4.102 -93.91%
|
Information
|
| O: -12.87%
H: 0.63%
C: -6.32%
Brooklyn ImmunoTherapeutics to Conduct Shareholder Update Conference Call on Monday, September 20, 2021, at 4:30 PM ET
Published: 2021-09-13 (Crawled : 13:00) - globenewswire.com
BTX 4 | $4.102 -93.91%
|
Information
|
| O: -0.33%
H: 11.54%
C: 3.76%
conference
Brooklyn ImmunoTherapeutics Announces Adjournment of Annual Meeting of Stockholders Due to Lack of Quorum
Published: 2021-08-20 (Crawled : 21:00) - globenewswire.com
BTX 4 | $4.102 -93.91%
|
Information
| Email alert
Add to watchlist
Brooklyn ImmunoTherapeutics Provides Highlights of Shareholder Update Call from August 19, 2021
Published: 2021-08-20 (Crawled : 13:00) - globenewswire.com
BTX 4 | $4.102 -93.91%
|
Information
|
| O: 1.58%
H: 7.44%
C: 6.67%
Brooklyn ImmunoTherapeutics to Conduct Shareholder Update Conference Call on Thursday, August 19, 2021 at 4:30 PM ET
Published: 2021-08-16 (Crawled : 23:00) - globenewswire.com
BTX 4 | $4.102 -93.91%
|
Information
|
| O: -4.58%
H: 7.93%
C: 3.92%
conference
Brooklyn ImmunoTherapeutics to Present at the SNN Virtual Investor Conference on August 18, 2021
Published: 2021-08-13 (Crawled : 19:00) - globenewswire.com
BTX 4 | $4.102 -93.91%
|
Information
| Email alert
Add to watchlist
conference
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
| 0001104659-23-095434 | 4 | 2023-08-25 | 2023-07-13 | Buy | P | 2307692 | 2307692 |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Last 48 Hours Insiders Buying
IZEA | $2.5 -2.4% 8.6K
|
Technology Services
|
00:00
RKT P 383 | $11.38 -0.52% 1.05% 1.4M
|
Finance
|
22:30
CTRN P 18090 | $22.46 -1.01% -1.02% 55K
|
Retail Trade
|
22:00
BRN P 10650 | $2.795 2.38% 0.18% 35K
|
Energy Minerals
|
21:00
NEOG P 10000 | $12.14 -0.16% -0.16% 3.1M
|
Health Technology
|
16:30
RMCF | $3.51 -3.7% -3.85% 3.8K
|
Consumer Non-Durables
|
20:10